Characterization of clinically significant strains of coagulase-negative staphylococci.
about
Ultrasonically enhanced vancomycin activity against Staphylococcus epidermidis biofilms in vivo.Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococciSpecies-level identification of staphylococcal isolates by real-time PCR and melt curve analysis.Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model.Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat modelEradication of biofilm-forming Staphylococcus epidermidis (RP62A) by a combination of sodium salicylate and vancomycinIsolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime.Structural and biological characterization of a capsular polysaccharide produced by Staphylococcus haemolyticus.Septicemia due to coagulase-negative Staphylococcus in a community hospital.Multivalent artificial opsonin for the recognition and phagocytosis of Gram-positive bacteria by human phagocytes.Effects of subinhibitory concentrations of vancomycin or cefamandole on biofilm production by coagulase-negative staphylococci.Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit.Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm.An estimate for the source of coagulase-negative staphylococci in blood cultures.Drug-resistant coagulase-negative skin staphylococci. Evaluation of four marker systems and epidemiology in an orthopaedic wardCharacterization of clinically significant isolates of Staphylococcus epidermidis from patients with cerebrospinal fluid shunt infections.Pediatric bacteremia due to Staphylococcus warneri: microbiological, epidemiological, and clinical features.Update on clinical significance of coagulase-negative staphylococciRole of the Staphylococcus epidermidis slime layer in experimental tunnel tract infections.Phenotypic variation of Staphylococcus epidermidis slime production in vitro and in vivo.Coagulase-negative staphylococci and the epidemiological typing of Staphylococcus epidermidis.Use of disinfectants to reduce microbial contamination of hubs of vascular catheters.Antimicrobic susceptibility and plasmid profile analysis as identity tests for multiple blood isolates of coagulase-negative staphylococci.Characterization of clinically significant isolates of Staphylococcus epidermidis from patients with endocarditisBiotyping coagulase-negative staphylococci.Slime production by bovine milk Staphylococcus aureus and identification of coagulase-negative staphylococcal isolates.Reactivity of coagulase-negative staphylococci isolated from cow and goat milk with monoclonal antibodies to Staphylococcus aureus capsular polysaccharide types 5 and 8.Collagen binding, elastase production, and slime production associated with coagulase-negative staphylococci isolated from bovine intramammary infections.Capsular polysaccharide serotyping scheme for Staphylococcus epidermidisCharacterization of Micrococcaceae strains isolated from the human urogenital tract by the conventional scheme and a micromethod.Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices.Identification of Staphylococcus spp. by PCR-restriction fragment length polymorphism of gap gene.The abilities of a Staphylococcus epidermidis wild-type strain and its slime-negative mutant to induce endocarditis in rabbits are comparable.Production of extra-cellular slime by Staphylococcus epidermidis during stationary phase of growth: its association with adherence to implantable devices.The ica operon and biofilm production in coagulase-negative Staphylococci associated with carriage and disease in a neonatal intensive care unit.Comparative in vitro activities of new fluorinated quinolones and other antibiotics against coagulase-negative Staphylococcus blood isolates from neutropenic patients, and relationship between susceptibility and slime production.Coagulase-negative staphylococci resistant to beta-lactam antibiotics in vivo produce penicillin-binding protein 2aInhibitory effect of disodium EDTA upon the growth of Staphylococcus epidermidis in vitro: relation to infection prophylaxis of Hickman catheters.Artificial opsonin enhances bacterial phagocytosis, oxidative burst and chemokine production by human neutrophils.Blood proteins do not promote adherence of coagulase-negative staphylococci to biomaterials.
P2860
Q24537569-9D6DBCDB-9209-48AF-8F39-6B352B90348EQ30450189-4D23493A-75C4-4F3A-85CB-3EDD2C3AB595Q33856216-01EDCE45-0259-4833-938C-5B3C47937FE6Q33867950-C3F263D2-0105-4C66-BF50-8B23BA5B7187Q33868064-D7F18CF1-3D4C-48D8-8C19-0BDC70607798Q33983463-566F6439-A407-4765-A528-0AE2BF33F409Q34523848-14C1EFD3-D6AF-4D0A-B074-120946FF8EA3Q34731479-4ED2C273-510D-45C4-8B78-ED7FAE326AD8Q34733933-A42626F9-EFF9-4F5A-A6E3-BF069AD0AC06Q34754245-CA53710E-58D2-48FA-B322-7ED8A4BD1F07Q35249874-CD793A13-F04C-4E63-B3E4-015E91EB5E87Q35714446-5FAECC69-0CA6-4D75-8204-827AEE0E3A7EQ35903859-A03389A1-2960-439F-97D3-A51AAF462C0DQ36472723-8BAC444C-BA8F-49B6-AF5C-388A17311896Q36504959-EDD31A7B-66F4-4110-A6A1-24AFB88660CBQ36505185-170A7ADD-7F7E-4F0A-8CE5-8BB82D90F34DQ36546030-06A54045-47F5-4EC8-9951-FFFC278839D4Q36640978-DE5772CB-B9FC-4D9D-B189-CD713CCBC75EQ36942887-E8A5245A-0D0D-4268-9815-8D728B0B64A0Q37008601-59C5D103-FAF6-4EC6-92BB-41EBB9F78767Q37061574-DAF9A876-DF79-46C8-A917-ECB083C3A4AAQ37065243-432057A2-3794-4C44-822A-D705EC9C944DQ37139326-57B7B128-4A08-4569-A611-5391005718FAQ37146505-3958CC14-9D0C-44DD-9B2B-A598E66002A8Q37155962-760AB55B-2C36-46E4-AA28-0A720A9B49A3Q37204570-EDC17411-9695-4A6B-BE65-C13DEC534BEAQ37226710-1019A447-0DDF-48BC-A2EE-5BFF70CB3C48Q37228233-EC625173-4B11-4510-AC37-A4BA71260501Q37252230-32847D40-3BD9-46D4-AD02-129C2A6DDAADQ37278377-C9AA854C-1846-4DCB-9459-9E3C1A9B72A7Q37283349-55AF465E-2D88-4105-ACA8-60570760ECB5Q39466557-BF4A22D1-2E8A-4026-9E61-CE42DDB4E7CCQ39571622-46C9CF75-903A-4CBC-9A60-02A85B67CDBBQ39654073-9AA313E4-DD65-4559-9024-F6095E6C8AF0Q39746593-EE1E7420-8D64-42CC-A993-2B71258FBBEDQ39814933-2FA57BC6-58B1-4553-8CFF-5EA4CB1CEE33Q39832125-3571497B-A54A-44C4-AC2B-EAB5F0BD9493Q39832599-27BFFE21-C87C-488F-AB07-860B0C1D9B4FQ40072409-D4C02666-6621-4EDD-95F7-F3D96351BBCEQ40151914-B937F4BB-41DC-4286-AC3C-066C7B9001C8
P2860
Characterization of clinically significant strains of coagulase-negative staphylococci.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1983
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization of clinically significant strains of coagulase-negative staphylococci.
@en
Characterization of clinically significant strains of coagulase-negative staphylococci.
@nl
type
label
Characterization of clinically significant strains of coagulase-negative staphylococci.
@en
Characterization of clinically significant strains of coagulase-negative staphylococci.
@nl
prefLabel
Characterization of clinically significant strains of coagulase-negative staphylococci.
@en
Characterization of clinically significant strains of coagulase-negative staphylococci.
@nl
P2093
P2860
P1476
Characterization of clinically significant strains of coagulase-negative staphylococci
@en
P2093
E H Beachey
G D Christensen
J T Parisi
W A Simpson
P2860
P304
P407
P577
1983-08-01T00:00:00Z